Cullinan Therapeutics, Inc. (CGEM)
15.51
+0.98
(+6.74%)
USD |
NASDAQ |
Oct 02, 16:00
15.50
-0.01
(-0.06%)
Pre-Market: 08:00
Cullinan Therapeutics Total Liabilities (Quarterly) : 42.03M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 42.03M |
| March 31, 2026 | 36.81M |
| December 31, 2025 | 40.41M |
| September 30, 2025 | 32.76M |
| June 30, 2025 | 28.18M |
| March 31, 2025 | 27.84M |
| December 31, 2024 | 32.10M |
| September 30, 2024 | 25.39M |
| June 30, 2024 | 25.00M |
| March 31, 2024 | 23.76M |
| December 31, 2023 | 31.20M |
| September 30, 2023 | 25.89M |
| June 30, 2023 | 22.41M |
| March 31, 2023 | 29.34M |
| Date | Value |
|---|---|
| December 31, 2022 | 26.09M |
| September 30, 2022 | 31.11M |
| June 30, 2022 | 62.63M |
| March 31, 2022 | 17.26M |
| December 31, 2021 | 11.81M |
| September 30, 2021 | 7.93M |
| June 30, 2021 | 5.813M |
| March 31, 2021 | 9.967M |
| December 31, 2020 | 14.39M |
| September 30, 2020 | 7.806M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 2.596M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Climb Bio, Inc. | 6.747M |
| MapLight Therapeutics, Inc. | 20.05M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 363.79M |
| Shareholders Equity (Quarterly) | 321.75M |
| Debt to Equity Ratio | 0.0064 |
| Current Ratio | 8.417 |
| Net Debt Paydown Yield | 0.00% |